Study Design:

Open Label, Randomized, Cross Over, Comparative Study

(20 male or female volunteers with Type-1 Diabetes)

Patients: received two treatments in a randomized fashion on separate days:

1. Insulin Injection*

2. PKA Micro-Needle Device*

*each with (Humalog, Lilly) 7 units at time 0 minutes

All subjects to consume 360 calories (Boost or Ensure Plus liquid Meals) 10 minutes after dose

Blood samples for plasma glucose and insulin taken 30 minutes before liquid meal

and after (15, 30, 60, 90, 120, 180, 240, 300 minutes)

 

HUMAN CLINICAL TRIAL TEST RESULTS

COMPARISON OF PKA MICRO-NEEDLE DEVICE AND

SUBCUTANEOUS INJECTION

Objective: to compare efficiency of PKA Micro-Needle based intra-dermal & epidermal drug delivery system with subcutaneous injection dose of human insulin after a standard breakfast meal in subjects with Type-1 Diabetes. Ely-Lilly's Rapid Acting Humalog insulin drug was used for the trial.

The PKA Micro-Needle is a Pain Free drug delivery method that replaces the traditional syringe
Logo

Changing the way  medicine is administered

Contact Us

TO LEARN MORE OR

FOR INVESTMENT OPPORTUNITIES...

Submitting Form...

The server encountered an error.

Form received.

GRAPHIC ANALYSIS OF THE ABOVE

Comparison Insulin Injection vs Micro-Needle

(Insulin Levels (uU/mL)

Comparison Insulin Injection vs Micro-Needle

(Glucose  (mg/dL)

TEST RESULTS & CONCLUSION

  • Absorption of insulin through the intra-dermal route was significantly faster when compared to subcutaneously injected rapid acting insulin (humalog)
  • 30 mins & 60 mins postprandial glucose level rapidly lowered with PKA Micro-Needle device vs. Subcutaneous injected group
  • Humalog peaked approximately 50% faster with 30 mins of intra-dermal injection (Tmax=30mins
  • Attributed to more rapid absorption of insulin through intra-dermal interstitial fluid with PKA Micro-Needle injection
  • No pain with the PKA Micro-Needle injection; patients never felt the pricking pain that is associated with the subcutaneous injection

The following article was written by two of PKA SoftTouch's founders:

Dr. Pankaj Modi and Maneesh Khanna - together with Marko Mihic.

The article provides information on early testing and results of the Micro-Needle.

Advanced Delivery Devices Article

Micro-Injection Atropine Study

SAFE, SIMPLE & PAIN FREE

THE PKA MICRO-NEEDLE REPLACES THE SYRINGE WITH A PAINLESS INTERDERMAL DELIVERY SYSTEM

Lakefield, ON

(705) 652-6100

info@pkasofttouch.com